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Abstract
Background: As malaria transmission declines in many regions of sub-Saharan Africa, interventions to identify the
asymptomatic reservoir are being deployed with the goals of improving surveillance and interrupting transmission.
Reactive case detection strategies, in which individuals with clinical malaria are followed up at their home and household residents and neighbours are screened and treated for malaria, are increasingly used as part of malaria elimination programmes.
Methods: A reactive screen-and-treat programme was implemented by the National Malaria Control Centre in
Southern Province, Zambia, in which individuals residing within 140 m of an index case were screened with a malaria
rapid diagnostic test (RDT) and treated if positive. The operational challenges during the early stages of implementing this reactive screen-and-treat programme in the catchment area of Macha Hospital in Southern Province, Zambia
were assessed using rural health centre records, ground truth evaluation of community health worker performance,
and data from serial cross-sectional surveys. The proportion of individuals infected with Plasmodium falciparum who
were identified and treated was estimated by simulating reactive screen-and-treat and focal drug administration
cascades.
Results: Within the 1st year of implementation, community health workers followed up 32 % of eligible index cases.
When index cases were followed up, 66 % of residents were at home in the index households and 58 % in neighbouring households. Forty-one neighbouring households of 26 index households were screened, but only 13 (32 %) were
within the 140-m screening radius. The parasite prevalence by RDT was 22 % in index households and 5 % in neighbouring households. In a simulation model with complete follow-up, 22 % of the total infected population would be
detected with reactive screen-and-treat but 57 % with reactive focal drug administration.
Conclusions: With limited resources, coverage and diagnostic tools, reactive screen-and-treat will likely not be sufficient to achieve malaria elimination in this setting. However, high coverage with reactive focal drug administration
could be efficient at decreasing the reservoir of infection and should be considered as an alternative strategy.
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Background
Substantial reductions in the burden of malaria have
been documented in parts of sub-Saharan Africa and
malaria elimination goals have been proposed at regional,
national and sub-national levels [1–3]. As areas make the
transition from malaria control to elimination, strategies
have been developed to target the population of chronically infected individuals who are asymptomatic yet can
contribute to transmission [4–9]. In malaria-endemic
areas, individuals develop clinical immunity to disease
after repeated exposure to parasites but can remain
infectious despite the absence of symptoms or develop
low-grade symptoms that would not prompt them to
seek care [10, 11]. As malaria transmission declines, the
proportion of the total infected population comprised of
asymptomatic, chronically infected individuals with low
parasite densities increases [12–15]. These individuals
constitute an asymptomatic reservoir that is less infectious than symptomatic, but are capable of transmitting
parasites in areas with competent vectors [12, 14, 15].
Several strategies have been developed to identify and
treat asymptomatic, chronically infected individuals.
Mass drug administration treats entire populations or
high-risk groups based on the fact that current pointof-care diagnostic tests are not sufficiently sensitive to
identify individuals with low-level parasitaemia [16, 17].
Active case detection, in contrast, involves screening
individuals for malaria with rapid diagnostic tests (RDTs)
within a defined geographic area (‘hot spots’) or high-risk
populations (‘hot pops’) at regular intervals and treating
those who test positive. Active case detection and focal
and mass drug administration aim to eliminate parasites
from chronically infected individuals, thus facilitating the
interruption of local transmission [18]. The World Health
Organization recommends that areas with moderate to
low malaria transmission implement active case detection as part of national malaria control and elimination
programmes [8].
One method of active case detection involves reactive
case detection, which leverages the underlying spatial
and temporal clustering of malaria [19–21]. Reactive case
detection includes reactive screen-and-treat and reactive focal drug administration. For reactive screen-andtreat, residents in the home of a symptomatic index case
and those in neighbouring households within a specified
distance are screened with an RDT and treated if positive [6, 22, 23]. With reactive focal drug administration,
individuals residing within an index case household
and potentially neighbouring households are treated
with anti-malarials without testing [24, 25]. The advantage of focal drug administration is that infected individuals are treated who may otherwise be missed with
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a low-sensitivity RDT [24, 25]. Uninfected individuals
are also treated but may benefit from chemoprophylaxis
[24–26].
The Government of Zambia created a stepped sequence
of interventions to achieve malaria elimination [27–29].
Designated as steps A through E, these interventions
are to be implemented in succession depending on the
parasite prevalence and case burden at health facilities
[28, 29]. Step D consists of training volunteer community health workers (CHWs) to perform reactive screenand-treat. Step D is implemented in low-transmission
communities in which the parasite prevalence is approximately 1 % and an average of ten or fewer malaria cases
present to a healthcare facility per week [28]. In 2013,
Step D activities were implemented through a phased
roll-out in selected districts in Southern Province, Zambia with the goals of improving surveillance and interrupting transmission [9, 27].
When an individual seeks care at a healthcare facility
(hospital, rural health centre or rural health post) and
tests positive for malaria by RDT, their eligibility for
follow-up with reactive screen-and-treat is determined.
CHWs exclude individuals with a reported travel history as these cases are presumed to be imported. Travel
is defined as staying overnight in a place outside their
home district within the previous month. RDT-positive
individuals who had not travelled are eligible for reactive
screen-and-treat. Eligible index cases are to be followed
up within 1 week of diagnosis. CHWs are trained to visit
the households of eligible index cases and neighbouring
households within 140 m of an index case, screen all residents with an RDT and treat everyone who tests positive [9].
The study was conducted in Kalomo, Namwala
and Choma Districts in Southern Province, Zambia
where the single rainy season lasts from November
through April, followed by a cool dry season from April
until August and a hot dry season through November. Malaria transmission peaks during the rainy season [30]. This area consists of villages comprised of
small, scattered homesteads. The primary malaria vector is Anopheles arabiensis [30, 31]. The prevalence
of malaria declined over the past decade, from 9 % in
2008 to less than 1 % in 2013 [32], generating interest
in malaria elimination. Challenges faced during the 1st
year of implementation of a reactive screen-and-treat
programme in southern Zambia were evaluated. RDT
availability, follow-up and coverage were assessed using
rural health centre (RHC) records and evaluation of
CHW performance. Additional data from serial crosssectional surveys were used to construct simulated
reactive case detection cascades.
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Methods
Study population

The study population for the record review and ground
truth survey consisted of individuals eligible for reactive
screen-and-treat from January to June 2014 as described
below. Results from the record review and ground truth
evaluation were used in combination with data from
serial cross-sectional surveys conducted in the catchment area of Macha Hospital from 2008 to 2013. For
these cross-sectional surveys, a random sample of households was selected using satellite imagery every other
month from February 2008 to December 2013. For each
study visit, informed consent was obtained from participants and a questionnaire was administered to collect information on demographic characteristics, recent
malaria symptoms and treatment, health-seeking behaviour, and knowledge of malaria risk and prevention. A
blood sample was collected by finger prick and tested by
RDT (ICT Malaria P.f, ICT Diagnostics South Africa).
Participants who tested positive were offered treatment
with artemether–lumefantrine (Coartem®) [23, 33].
Record review of reactive screen‑and‑treat

The reactive screen-and-treat programme started in the
study area in May 2013. During the low-transmission
season from July to September 2014, a study team from
Macha Research Trust visited ten RHCs in Kalomo,
Choma and Namwala Districts and abstracted data on
reactive screen-and-treat from January to June 2014
(within the 1st year of step D implementation) from 20
rural health posts (RHPs) serving the catchment areas
of the ten RHCs. RHPs are the lowest level of stationary
healthcare and are staffed by volunteer CHWs. The number of RDTs received by a RHP, tests performed, RDTpositive malaria cases identified, malaria cases eligible
for reactive screen-and-treat, and eligible malaria cases
followed up were recorded for each month. Reported
reasons why eligible cases were not followed up were
documented. Since 2013, healthcare facilities used the SD
Bioline Malaria Ag P.f (Standard Diagnostics Inc, Republic of Korea).
Ground truth evaluation of reactive screen‑and‑treat

To ground truth reactive screen-and-treat performance,
study staff visited ten RHPs associated with seven parent
RHCs from July to September 2014 and identified index
cases with RDT-confirmed malaria that triggered reactive screen-and-treat. Study staff then randomly selected
26 index case households that were screened during Step
D activities between January and June 2014 for ground
truth evaluation. The study staff and CHW visited the
selected index case households and neighbouring households determined to be eligible for screening by the
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CHW. The study team recorded the number of residents
within each household, the number of residents at home
and tested by the CHW, the number of RDT-positive
residents, the number of residents treated for malaria,
and the distance from the index case household to neighbouring households (using a GPS-enabled device). The
time from identification of the index case to reactive
screen-and-treat was calculated when dates were available. Data on age and sex were collected retrospectively
from RHP records.
Construction of simulated reactive case detection cascades

The proportion of infected individuals identified and
treated through reactive case detection was modelled.
First, data collected through serial cross-sectional surveys were used to estimate the number of total residents
and Plasmodium falciparum-infected residents in index
and neighbouring households. Details of the model were
previously described [23]. In brief, all households in the
study area were enumerated from satellite imagery and
data from serial cross-sectional surveys were used to predict the number of residents per non-sampled household
and the total number of infected individuals positive for
P. falciparum by PCR in non-sampled households based
on an ecological risk map [23]. Second, the proportion of
infected individuals who were symptomatic (i.e., documented tympanic temperature ≥38 °C or self-reported
fever in previous 48 h) was estimated using data from
the serial cross-sectional surveys and extrapolated to
non-sampled households. Third, the proportion of symptomatic, infected individuals who sought care from a
healthcare facility during their last febrile episode was
estimated using data from the serial cross-sectional
surveys and extrapolated to the estimated number of
symptomatic-infected individuals in the non-sampled
households. Fourth, a sensitivity of 95 % was used to
determine the proportion of symptomatic-infected individuals who would be RDT-positive upon presentation
to a healthcare facility [34]. Fifth, data from the record
review and ground truth evaluation were used to determine the median number of neighbouring households
per index household that would be screened as well as
the parasite prevalence by RDT in index and neighbouring households. Sixth, the sensitivity of the RDT to detect
asymptomatic infection was estimated to be 40 % in
index households and 23 % in neighbouring households
compared to PCR, based on unpublished data comparing
RDT and PCR results in the study area. These sensitivities were used to back-calculate the estimated number of
infected individuals in index and neighbouring households. Specifically, the inverse of RDT sensitivities for
index (1/0.4) and neighbouring households (1/0.23) were
multiplied by the estimated number of RDT-positive
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individuals to estimate the total number of infected
individuals.
This model was used to estimate the proportion
of infected individuals identified and treated under
observed and complete coverage with reactive screenand-treat. The model was also used to determine the
proportion of infected individuals treated using reactive
focal drug administration in the index households only.
The sensitivity of the model under varying assumptions,
including RDT prevalence in index and neighbouring
households, RDT sensitivity, and the ration of symptomatic to asymptomatic cases, was estimated. These
results are presented in the Additional files 1, 2, 3.

Results
Record review of reactive screen‑and‑treat

Records reviewed at the ten RHCs indicated that 411
malaria cases were passively identified by RDT from January to June 2014 at the 20 RHPs. Of these, 21 cases were
excluded by the CHWs based on reported travel history
and 394 were considered eligible for follow-up with reactive screen-and-treat. Of those eligible, 32 % (n = 126)
were followed up. The primary reason households were
not followed up was insufficient RDTs.
As expected, a seasonal pattern of malaria cases was
observed, with the number of cases increasing after
January and peaking in April (Fig. 1). As the number of
malaria cases increased, the proportion followed up
decreased (Fig. 1). When RHPs were stratified by malaria
burden (high malaria burden was defined as those with
20 or more eligible cases per month), high-burden RHPs
had poorer follow-up as the burden of reactive case
detection exceeded capacity (Fig. 1). Over half of the
RHPs (n = 11) reported at least 1 month without sufficient RDTs to follow up eligible index cases, and eight of
these RHPs reported at least 1 month without sufficient
RDTs to perform passive case detection. Low-burden
RHPs reported more months with insufficient RDTs than
high-burden RHPs. The parent RHCs did not report RDT
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stock-outs, suggesting challenges in distributing RDTs
from RHCs to RHPs.
Ground truth evaluation of reactive screen‑and‑treat

The CHW registers identified 63 neighbouring households associated with the 26 index case households as eligible for reactive screen-and-treat (89 total households)
(Table 1). Study staff collected coordinates and household demographics for all 26 index case households and
89 % (n = 56) of the 63 neighbouring households, as no
one was home at seven households (Fig. 2). Twenty-two
neighbouring households were not screened by CHWs
(35 % of 63), of which 12 (55 %) were not screened due to
a lack of RDTs, representing 19 % of the 63 eligible households. Of the 41 neighbouring households screened by the
CHW, only 13 (32 %) were within 140 m of an index case
household (Table 1). Study staff identified 21 households
within 140 m of an index household (eight more than the
CHWs) and data were collected from 18 (86 %) of these
households, as no one was home at three households
(Table 1). Thus, the percentage of eligible neighbouring
households within 140 m of an index household screened
by the CHWs was 62 % (13 of 21) (Table 1). The median
number of households screened per index case households was three (IQR 1, 3; minimum = 1; maximum = 8).
For the 26 index cases selected for evaluation, 705 individuals residing in 82 households were eligible for reactive screen-and-treat, 261 in index households and 444
in neighbouring households (Table 1). Overall, 428 individuals (61 %) were recorded to have been screened in
the CHW registers. In index case households, 66 % of the
residents were reported to be screened compared with
58 % in neighbouring households (p = 0.04) (Table 1).
Within the 18 neighbouring households within 140 m
for which data were available, 100 (61 %) of 165 eligible
individuals were screened by the CHW (Table 1). The
parasite prevalence by RDT was 22 % among residents of
index case households and 5 % among residents of neighbouring households (Table 1).

Fig. 1 Malaria cases reported and followed up with reactive screen-and-treat by month from record review. a All RHPs, b high burden RHPs, c low
burden RHPs
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Table 1 Ground-truth evaluation of reactive screen-and-treat: household and individual characteristics
Index

Neighbouring

Total

Household characteristic
Indicated eligible for RCD by CHW (%)

26 (100)

63 (100)

Identified by study staff (%)

26 (100)

56 (89)

89 (100)
82 (92)

Recorded in CHW register (%)

26 (100)

41(65)

67 (75)

Within 140 m of index household (%)

NA

21(33)

NA

Within 140 m of index household in CHW register (%)

NA

13 (21)

NA

Resident characteristic
Indicated eligible for RCD by CHW in 82 households with data (%)

261 (100)

444 (100)

705 (100)

Screened and recorded in CHW register (%)

171 (66)

257 (58)

428 (61)

Within 140 m of index household (%)

NA

165 (37)

NA

Within 140 m of index household in CHW register (%)

NA

100 (23)

NA

RDT positive (% of all RDTs)

37 (22)

13 (5)

50 (12)

RDT negative (% of all RDTs)

134 (78)

244 (95)

378 (88)

RCD reactive case detection, CHW community health worker, RDT rapid diagnostic test

Fig. 2 Index households included in the ground-truth evaluation of reactive screen-and-treat

The median time between when an index case presented to a healthcare facility and the reactive screenand-treat was 3 days (IQR = 2–5.5; minimum = 1;
maximum = 12). The median distance from the index
household to the neighbouring households screened
was 194 m (IQR = 117–303; minimum = 36; maximum = 530 m). Thirty-two per cent of all neighbouring
households screened by the CHWs were within 140 m
of the index case household, suggesting the CHWs
had difficulty delineating the 140-m radius. Thirteen

RDT-positive individuals were detected in index and
neighbouring households. Only one RDT-positive individual (7.7 %) was within 140 ms of the index case
household. However, 92 % (n = 12) of all RDT-positive
individuals resided within 250 m of the index household
(Table 2).
Demographic information was collected from 449
individuals eligible for screening by reactive screenand-treat, 99 from index case households and 350 from
neighbouring households. No overall differences in
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Table 2 Cumulative numbers of neighbouring households, individuals, and RDT-positive cases by distance from index
households identified through the ground-truth evaluation of reactive screen-and-treat
140 m

250 m

300 m

350 m

400 m

450 m

500 m

550 m

Households indicated as eligible by CHW (% indicated as eligible)

21 (33)

40 (64)

47 (75)

49 (78)

55 (87)

59 (93)

62 (98)

Households screened by CHW (% households screened)

13 (32)

28 (68)

30 (73)

32 (78)

35 (85)

37 (90)

40 (98)

41 (100)

Residents in screened households (% residents screened)

78 (30)

182 (71)

196 (76)

214 (83)

236 (92)

239 (93)

254 (99)

257 (100)

1 (8)

12 (92)

12 (92)

RDT positive cases in screened households (% RDT positive cases)

13 (100)

13 (100)

13 (100)

13 (100)

63 (100)

13 (100)

RDT rapid diagnostic test, CHW community health worker

screening by sex were observed (49.5 % male, 50.7 %
female, p = 0.21) or when stratified by household type
(index: 41.6 % male, 58.4 % female, p = 0.28; neighbouring: 51.3 % male, 48.7 % female, p = 0.32). Residents of
index and neighbouring households did not differ by
age (index: median age = 13.5 years IQR = 7–23 years;
neighbouring: median age = 14 years IQR = 6–26 years,
p = 0.75). However, residents who were screened were
younger than those who were not (screened: median
age = 13 years, IQR = 6–25 years; not screened: median
age = 19 years, IQR = 12–31 years, p < 0.01).
Reactive case detection cascades

A flow diagram of the reactive screen-and-treat and focal
drug administration cascade construction and estimates
is presented in Fig. 3. The total population of the study
area was estimated to be 32,370 individuals and the P.
falciparum parasite prevalence by PCR was estimated
to be 2.9 % (937 infections) [23]. Based on data from the
serial cross-sectional surveys, 23 % (n = 214) of the 937
PCR-positive individuals were estimated to be symptomatic (i.e., febrile), with 36 % (n = 76) estimated to seek
care at a healthcare facility and thus be potentially eligible to trigger reactive screen-and-treat (Fig. 3). Using an
RDT sensitivity of 95 % for uncomplicated malaria, 73 of
these individuals would be identified as having malaria
at a healthcare facility (Fig. 3) [34]. The proportions of
RDT-positive residents in the index and neighbouring
households were estimated based on the RDT prevalence
observed during the record reviews (22 % in index households and 5 % in neighbouring households) to capture the
local spatial dependence of malaria transmission (Fig. 3).
Based on the eligibility criteria in which persons with
recent travel are excluded, 5 % of RDT-positive symptomatic cases were estimated to be ineligible for reactive
screen-and-treat (Figs. 4, 5, 6, 7). Thus, 95 % (n = 69)
of the RDT-positive index cases were estimated to be
eligible for reactive screen-and-treat. These cases represented 7 % (69 of 937) of the total infected population
(Figs. 4a, 5, 6, 7a). Based on estimates of household size,
an average of five household residents would be screened
within each of the 69 index households, yielding 345 residents, with 22 % (n = 76) estimated to be RDT positive

(Fig. 4a). Given a 40 % sensitivity of the RDT in index
households, 189 infected individuals (20 % of total infections) were estimated to reside within the index households (Fig. 4a) [35]. With complete follow-up, in which
all index household residents were screened, 16 % (73
symptomatic RDT-positive index cases and 76 RDT-positive individuals residing within the index case household)
of all infected individuals would be detected and treated
through reactive screen-and-treat in the index households (Fig. 4a).
When neighbouring households were included in the
model, 270 infected individuals were estimated to reside
in the 207 neighbouring households of the 69 index
households (Fig. 4b), representing 29 % of all infected
individuals. Of these infected individuals, 62 (7 % of all
infected individuals) were estimated to be RDT-positive
based on an RDT sensitivity of 23 %. Screening neighbouring households of the index case household would
increase the percentage of the total infected population
detected and treated from 16 to 22 %, assuming complete
follow-up of all eligible index cases and neighbouring
households, and with all residents at home and willing to
be screened (Fig. 4b).
Using the same data consisting of 69 index cases,
189 infected individuals in index households, and 270
infected individuals in neighbouring households, the
effectiveness of reactive focal drug administration was
simulated. In this analysis, the sensitivity of the RDT
for asymptomatic infected individuals is not relevant as
residents are treated without testing. With complete follow-up of all eligible index cases, 28 % (n = 258), of all
infected individuals would be treated through focal drug
administration at the index household (Fig. 5a). When
neighbouring households were included, 57 % (n = 531)
of all infected individuals would be treated through focal
drug administration (Fig. 5b).
These data were also used to model the proportion of
infected individuals treated under the coverage observed
during the RHC evaluation and ground truth surveys, in
which follow-up of eligible index cases was only 32 %.
In index households, 66 % of the residents were at home
during screening and 58 % were at home in neighbouring households. Under observed coverage, screening and
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Fig. 3 Reactive screen-and-treat flow diagram for complete coverage

treating index case households would have detected and
treated only 9 % of the total infected population (Fig. 6a),
which increased to 11 % of the total infected population
when neighbouring households were included (Fig. 6b).
The same observed coverage was used to model focal
drug administration. Under observed coverage, 11 %
of all infected individuals in the population would have
been treated (Fig. 7a), which increased to 17 % when
neighbouring households were included (Fig. 7b).
The cascades identified key areas that impact the effectiveness of reactive case detection to identify and treat
infected individuals, including the ratio of symptomatic
to asymptomatic infections, care-seeking behaviours and
the RDT sensitivity (Fig. 8).

Discussion
Implementation of reactive screen-and-treat in this area
of southern Zambia faced several operational challenges,
as would be expected with a new programme using volunteer CHWs and RDTs to expand clinical services into
the community. Approximately one-third of eligible
index case households resulted in reactive screen-andtreat and coverage decreased to one-quarter among

RHCs with a higher burden of malaria. This low coverage
was likely due to two factors. First, the follow-up screening was logistically difficult for CHWs due to the high
number of cases during the peak malaria season. Step
D activities were designed to be implemented when the
number of malaria cases is approximately ten per week.
Despite historically low transmission in this setting, some
RHCs reported more than 70 eligible cases per month
during the peak transmission season. This overwhelmed
the capacity of the CHWs to conduct reactive case detection. During peak transmission times the programme
would benefit from having additional CHWs available, or
perhaps consider suspending reactive case detection during peak transmission.
The second challenge was insufficient RDTs as a consequence of the high number of cases and difficulty in
anticipating the additional quantity of RDTs needed to
conduct reactive case detection. Over 50 % of CHWs
reported having at least 1 month when reactive screenand-treat was not done due to lack of RDTs, and 40 %
of CHWs reported at least 1 month when not even passive screening with RDTs could be performed. During
this period, the parent RHCs did not report stock-outs
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Fig. 4 Coverage cascades of reactive screen-and-treat with complete coverage of index and neighbouring households. a Index households only, b
index households and neighbors

or limited RDTs, implying delays, interruptions, or failures by RHC staff in distributing sufficient RDTs to the
CHWs during the initial stages of implementing the reactive case detection programme. Following CHW training,
a moderate stock of RDTs was provided to CHWs and
RHC staff were notified that additional RDTs should be

requested and released to CHWs to support Step D activities. Clearly to implement Step D, a reliable and ample
supply of RDTs is necessary; however, the rapid seasonal
changes in transmission makes predicting the required
number of RDTs challenging and surge capacity may not
be feasible. Over time, programmes should improve their
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Fig. 5 Coverage cascades of reactive focal drug administration with complete coverage of index and neighbouring households. a index households only, b index households and neighbors

ability to predict need and maintain an adequate stock of
RDTs at the level of the RHPs. However, the cost may be
that RDTs are stockpiled at these facilities and, if unused,
may expire.
When eligible index cases were followed up, three
main challenges were identified that hindered the ability
to identify infected individuals through reactive screenand-treat. First, only one-half to two-thirds of residents

were at home at the time of screening and residents not
at home were older than those at home. Those not at
home included school-age children and young adults,
the age group most commonly comprising the chronically infected reservoir that reactive case detection
aims to identify and treat [3]. This challenge could be
overcome. Notifications could be made to let individuals know when the CHW would be visiting. Households
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Fig. 6 Coverage cascades of reactive screen-and-treat with observed coverage of index and neighbouring households. a Index households only, b
index households and neighbors. a Index households only, b index households and neighbors

could be revisited to attempt to access those unable to
be at home during the first visit. Second, while theoretically simple, identifying households within 140 m (the
distance of one-and-a-half football fields) of an index
case was difficult for the CHWs in practice. Sixty-eight
per cent of neighbouring households screened by CHWs
were outside the 140-m radius. Some CHWs screened

neighbouring households over half a km from an index
case household. While reactive screen-and-treat programmes in other countries screen further from the
index household, in this setting nearly all RDT-positive
individuals were within 250 m of the index household
[6, 22, 36]. This demonstrates not only the difficulty in
identifying the appropriate screening radius, but also the

Searle et al. Malar J (2016) 15:412

Page 11 of 14

Fig. 7 Coverage cascades of reactive focal drug administration with observed coverage of index and neighbouring households. a Index households only, b index households and neighbors

burden of unnecessary screening given the lack of RDTs
and logistical challenges when the case burden is high.
Lastly, as is widely recognized, the low sensitivity of
RDTs limits the ability to identify individuals with lowlevel parasitaemia in areas approaching malaria elimination [14, 37, 38]. Even with complete follow-up, and
with an RDT sensitivity of 40 % in index households and

23 % in neighbouring households, only 16 % of infected
individuals were estimated to be identified by screening all index households and 22 % of infected individuals by screening neighbouring households. While the
infectiousness of individuals with low parasitaemia is
variable, a large portion of the malaria reservoir in this
area would be not treated. Given the poor sensitivity of
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Fig. 8 Key areas impacting the efficiency of reactive screen-and-treat on index and and neighbouring households

RDTs in this low-transmission setting, and the current
lack of more sensitive field-deployable diagnostics, reactive focal drug administration may be a more efficient
use of resources [17, 24]. With complete coverage, under
the assumptions of the model, potentially 60 % of the
total infected population in this setting would be treated
through reactive focal drug administration of index and
neighbouring households. However, complete coverage
will be logistically difficult, and many improvements in
follow-up strategies, including gauging neighbouring
household distances, would need to be made [24].
A major limitation of this study was the short period of
evaluation covering the rainy season but not the dry season.
The study period (January to June 2014) only represents a
six-month window where the evaluation was implemented.
In addition, this period reflects early programme implementation. These limitations will likely underestimate the
efficiency of the CHWs to react to incident cases as CHWs
received continuous training and encouragement following the implementation of the programme and follow-up
is easier during the dry season [9]. However, programmes
implementing reactive case detection strategies can learn
from this experience. These results highlight the need for
monitoring and evaluation shortly after implementation to
identify operational challenges and their potential impact
on programme performance and impact early on.

A strength of the RHC survey is that demographic
data on the number of residents not in the home at the
time of screening were collected. The reactive screenand-treat cascade used population-based survey data
from the study area in Choma District. Information from
Kalomo and Namwala Districts were not represented
in these data; however, the people residing within the
three districts are traditional subsistence farmers and
are demographically similar. The model did not account
for care seeking outside the government health facilities
and assumed that all infected, symptomatic individuals
sought care from government health facility, which may
have overestimated the number of index cases detected
through this system. However, the objective for creating
the cascades was to provide estimates of the proportion
of infected individuals identified and treated through
reactive screen-and-treat and focal drug administration
using multiple novel data sources.

Conclusion
With limited resources, coverage and diagnostic tools,
reactive screen-and-treat will likely not be sufficient to
achieve malaria elimination in this setting. However, high
coverage with reactive focal drug administration could
be efficient at decreasing the reservoir of infection and
should be considered as an alternative strategy.
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